Clinical Practice Guideline

Paget's Disease of Bone

December 19, 2014

Full Guideline: Paget's Disease of Bone: An Endocrine Society Clinical Practice Guideline
JCEM December 2014

Frederick R. Singer, Henry G. Bone, III, David J. Hosking, Kenneth W. Lyles, Mohammad Hassan Murad, Ian R. Reid, Ethel S. Siris

Objective:

The aim of this guideline was to formulate practice guidelines for the diagnosis and treatment of Paget's disease of the bone.

Conclusions:

  • We recommend that plain radiographs be obtained of the pertinent regions of the skeleton in patients with suspected Paget's disease.
  • If the diagnosis is confirmed, we suggest that a radionucleotide bone scan be done to determine the extent of the disease.
  • After diagnosis of Paget's disease, we recommend measurement of serum total alkaline phosphatase or, when warranted, a more specific marker of bone formation or bone resorption to assess the response to treatment or evolution of the disease in untreated patients.
  • We suggest treatment with a bisphosphonate for most patients with active Paget's disease who are at risk for future complications.
  • We suggest a single 5-mg dose of iv zoledronate as the treatment of choice in patients who have no contraindication.
  • In patients with monostotic disease who have a normal serum total alkaline phosphatase, we suggest that a specific marker of bone formation and bone resorption be measured, although these may still be normal.
  • Serial radionuclide bone scans may determine the response to treatment if the markers are normal.
  • We suggest that bisphosphonate treatment may be effective in preventing or slowing the progress of hearing loss and osteoarthritis in joints adjacent to Paget's disease and may reverse paraplegia associated with spinal Paget's disease.
  • We suggest treatment with a bisphosphonate before surgery on pagetic bone.

arrow Read the Full Guideline

CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Download our CPG Mobile App

Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.